Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis

[1]  Zhao-chun Chi.  Pathogenesis of non-alcoholic fatty liver disease , 2017 .

[2]  Kristopher J. Stanya,et al.  A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid utilization , 2013, Nature.

[3]  Hiroki Nakanishi,et al.  Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy. , 2013, Journal of molecular and cellular cardiology.

[4]  A. Lentsch,et al.  Ceramide mediates lung fibrosis in cystic fibrosis. , 2013, Biochemical and biophysical research communications.

[5]  S. Niida,et al.  Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease , 2013, Lipids in Health and Disease.

[6]  Hailin Chen,et al.  Similarity-based methods for potential human microRNA-disease association prediction , 2013, BMC Medical Genomics.

[7]  V. Zammit.  Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia. , 2013, The Biochemical journal.

[8]  Kenji Suzuki,et al.  A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma , 2013, Medical Molecular Morphology.

[9]  J. Ohsumi,et al.  A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis. , 2013, Biological & pharmaceutical bulletin.

[10]  Youping Deng,et al.  Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus , 2013, BMC Medical Genomics.

[11]  R. Matsumori,et al.  Elovl6 promotes nonalcoholic steatohepatitis , 2012, Hepatology.

[12]  A. Tager,et al.  Sphingolipid Regulation of Tissue Fibrosis , 2012, The open rheumatology journal.

[13]  I. Čavar,et al.  Anti-thromboxane B2 antibodies protect against acetaminophen-induced liver injury in mice , 2011 .

[14]  K. Tsuneyama,et al.  IL-4 mediates dicloxacillin-induced liver injury in mice. , 2011, Toxicology letters.

[15]  R. Taguchi,et al.  Precise and global identification of phospholipid molecular species by an Orbitrap mass spectrometer and automated search engine Lipid Search. , 2010, Journal of chromatography. A.

[16]  M. Colombini.  Ceramide channels and their role in mitochondria-mediated apoptosis. , 2010, Biochimica et biophysica acta.

[17]  G. Kristiansen,et al.  Expression of fatty acid synthase in nonalcoholic fatty liver disease. , 2010, International journal of clinical and experimental pathology.

[18]  Michelle M Wiest,et al.  The plasma lipidomic signature of nonalcoholic steatohepatitis , 2009, Hepatology.

[19]  Thomas Hankemeier,et al.  Analytical strategies in lipidomics and applications in disease biomarker discovery. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  John Turk,et al.  Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver , 2009, Cell.

[21]  M. Weller,et al.  Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis , 2008, Nature Medicine.

[22]  Takao Shimizu,et al.  Basic analytical systems for lipidomics by mass spectrometry in Japan. , 2007, Methods in enzymology.

[23]  Zamir Halpern,et al.  Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[24]  I. Leclercq,et al.  COX‐2 induction in mice with experimental nutritional steatohepatitis: Role as pro‐inflammatory mediator , 2006, Hepatology.

[25]  Jeanne M Clark,et al.  The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults , 2006, Journal of clinical gastroenterology.

[26]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[27]  N. Yoshiike,et al.  Epidemiological aspects of obesity and NASH/NAFLD in Japan. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[28]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[29]  Xianlin Han,et al.  Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. , 2005, Mass spectrometry reviews.

[30]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[31]  J. Sung,et al.  Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2 , 2004, Modern Pathology.

[32]  Keith D. Lindor,et al.  Nutritional and Metabolic Considerations in the Etiology of Nonalcoholic Steatohepatitis , 2001, Digestive Diseases and Sciences.

[33]  Robert V Farese,et al.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. di Sario,et al.  Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat , 2003, Hepatology.

[35]  Sang-hun Park.  Expanding the Natural History of Nonalcoholic Steatohepatitis: from Cryptogenic Cirrhosis to Hepatocellular Carcinoma , 2003 .

[36]  K. Jeong,et al.  Subcellular redistribution of protein kinase C isozymes is associated with rat liver cirrhotic changes induced by carbon tetrachloride or thioacetamide , 2001, Journal of gastroenterology and hepatology.

[37]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[38]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[39]  A. Mahfoudi,et al.  Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR) , 1993, Biology of the cell.

[40]  K. Mak,et al.  Attenuation of alcohol‐induced hepatic fibrosis by polyunsaturated lecithin , 1990, Hepatology.

[41]  S. Auerbach,et al.  Impact of ethnicity , 1985 .

[42]  M. Berridge.  Inositol trisphosphate and diacylglycerol as second messengers. , 1984, The Biochemical journal.